Alvesco (ciclesonide) NDC 70515-712

NDC codes

FDA NDC Directory

Product NDC (as listed)70515-712Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70515-0712Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70515-712-01	70515071201	1 INHALER in 1 CARTON (70515-712-01) / 60 AEROSOL, METERED in 1 INHALERMarketed from Mar 26, 2018
70515-712-02	70515071202	1 INHALER in 1 CARTON (70515-712-02) / 60 AEROSOL, METERED in 1 INHALERMarketed from Mar 26, 2018 · Sample package
70515-712-03	70515071203	1 INHALER in 1 CARTON (70515-712-03) / 30 AEROSOL, METERED in 1 INHALERMarketed from Apr 30, 2021
70515-712-04	70515071204	1 INHALER in 1 CARTON (70515-712-04) / 30 AEROSOL, METERED in 1 INHALERMarketed from Apr 30, 2021
70515-712-05	70515071205	1 INHALER in 1 CARTON (70515-712-05) / 60 AEROSOL, METERED in 1 INHALERMarketed from Apr 30, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Alvesco
Generic name (nonproprietary): ciclesonide
Active ingredients: Ciclesonide — 160 ug/1
Dosage form: Aerosol, Metered
Route: Respiratory (Inhalation)
Labeler: Covis Pharma US, Inc
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021658
Marketing start: Mar 26, 2018
Listing expires: Dec 31, 2026
Identifiers: Product ID 70515-712_3a8b4338-890b-bc2f-e063-6394a90ab578SPL ID 3a8b4338-890b-bc2f-e063-6394a90ab578SPL set ID 9f6112fb-78ef-43cf-8ae3-36370eb45468RxCUI 799034, 799037, 799038, 799040UNII S59502J185

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N470515071201 followed by a unit qualifier and the quantity

Package 70515-0712-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 28, 2025.

Indications (excerpt from the label)

ALVESCO is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 12 years of age and older. Limitations of Use : ALVESCO is not indicated for the relief of acute bronchospasm. ALVESCO is not indicated for children under 12 years of age. ALVESCO is an inhaled corticosteroid indicated for maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 12 years of age and older. ( 1 ) Limitations of Use : ALVESCO is not indicated for the relief of acute bronchospasm or in pediatric patients less than 12 years of age. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 021658

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021658
Product	Strength	Form · route	Labeler	Product NDC
Alvescociclesonide	Ciclesonide 80 ug/1	Aerosol, MeteredRespiratory (Inhalation)	Covis Pharma US, Inc	70515-711